Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

The Wellcome Foundation claims nitric oxide synthase inhibitors

Aug. 23, 1996

Nitric oxide synthase inhibitors from Merck & Co.

Aug. 23, 1996

BASF reveals NMDA and AMPA antagonists

Aug. 23, 1996

UPF-596 described as a novel glutamate antagonist

Aug. 23, 1996

Study of senile plaques guide Alzheimer's development

Aug. 23, 1996

Study indicates that estrogen may delay Alzheimer's disease onset

Aug. 23, 1996

Biogen signs Avonex distribution agreements

Aug. 23, 1996

Positive study results reported for CytoTherapeutics' encapsulated hCNTF device

Aug. 23, 1996

5-HT1D antagonists claimed by SmithKine Beecham

Aug. 23, 1996

Allelix describes dopamine D4 ligands for schizophrenia

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...